Market Highlights:
The portfolio of pharmaceutical companies has
become more diversified in recent years with the arrival of nanotechnology,
tissue regeneration, and stem cell research. These new products need a process
of manufacture and distribution need to be safer than conventional chemical
molecules by their intrinsic characteristics. In addition, the substantial
growth of emerging markets, the environmental pressures for sustainable
progress and the growing scrutiny by regulatory authorities (new regulations,
broader risk management, etc.) back the idea that a new approach to
manufacturing and distribution would be needed in future years to meet the
needs of the coming future.
The Global Blockchain In Pharmaceutical Supply Chain
Management Market is expected to register an
approximate CAGR of 22.5% during the forecast period of
2019–2024.
Key Players:
·
IBM
·
Microsoft
·
SAP SE
·
Oracle
·
Tibco
Software
·
Auxesis Group
·
Omnichain
·
Vechain
Foundation
·
Chainvine
·
Applied
Blockchain
·
AWS
·
Huawei
·
Guardtime
Segmentation:
The global blockchain in pharmaceutical supply
chain management is segmented on the basis of application, end user, and
region.
On the basis of application, the global blockchain
in pharmaceutical supply chain management market is segmented into product traceability, risk and compliance management,
payment & settlement, others. The market by end user is segmented
into manufacturers, distributors, healthcare providers
On the bases of region, the global blockchain in
pharmaceutical supply chain management market is segmented into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa. The Americas is
expected to hold the largest market share and the Middle East & Africa with
a low market share during the forecasted period.
Regional Analysis:
The healthcare sector and its supporting IT
infrastructure are going through dramatic changes, all of which impact the
claims management process and lead to improving the technology. Many healthcare
organizations use robotic process automation, intelligent EDI integration,
insurance discovery, and patient solutions all within their workflow platform
to dramatically enhance the overall process. The adoption of various software
has increased profit.
Infrastructure and technology are continuously
evolving in developing regions such as Asia-Pacific. A number of different
multinational and local companies are involved in developing their markets in
this region owing to the developing economy and increasing government support.
An increasing number of healthcare companies have provided a good opportunity
for the development of the blockchain in pharmaceutical supply chain management
market.
Furthermore, in the United States, the Drugs
Quality and Safety Act (DQSA) was promoted by Congress on November 27, 2013.
This outlines the steps to be taken to develop an interoperable electronic
supply chain management system. This will strengthen the FDA's capability to
protect consumers from exposure to drugs that could be fake or from the black
market.
No comments:
Post a Comment